News

Recent Net Asset Value Announcement for Octopus AIM VCT 2

Recent Net Asset Value Announcement for Octopus AIM VCT 2

Latest Net Asset Value Update

Octopus AIM VCT 2 plc has shared important financial information regarding its net asset value, which is crucial for investors. The current net asset value of the Ordinary shares stands at approximately 42.1 pence per share. This reflects the overall performance and valuation of the company's assets, providing insight into its financial health and investment potential.

Understanding Net Asset Value

Net Asset Value (NAV) is a fundamental metric used by investors to assess the value of an investment fund's assets minus its liabilities. The NAV provides an indication of the per-share value of a company's assets, which helps investors gauge the fair market value of their investments. For Octopus AIM VCT 2 plc, the reported NAV is a significant piece of information, enabling stakeholders to make informed decisions.

Importance of Regular Updates

Regular updates about the net asset value are essential to maintain transparency with investors. They help in tracking the performance of the company and understanding how market fluctuations impact the overall valuation of shares. The announcement regarding the NAV as of mid-October is timely and reflects Octopus AIM VCT 2 plc's commitment to keeping its investors informed.

About Octopus AIM VCT 2 plc

Octopus AIM VCT 2 plc is an established investment company focusing on providing capital to growing companies listed on the Alternative Investment Market (AIM) in the UK. The company's strategy aims to generate long-term capital growth by investing in a diverse range of sectors. Investors can benefit from potential returns while also enjoying the advantages of venture capital trust tax reliefs.

Contact Information

For further inquiries regarding the net asset value or other investment opportunities with Octopus AIM VCT 2 plc, you may reach out to:

Rachel Peat
Octopus Company Secretarial Services Limited
Tel: +44 (0)80 0316 2067

Additionally, the company's LEI is 213800BW27BKJCI35L17, ensuring compliance with regulatory requirements and providing further assurance to investors.

What to Expect Going Forward

Investors in Octopus AIM VCT 2 plc can expect ongoing communication regarding the performance of their investments. The transparency of information, such as the net asset value updates, is critical in building trust and facilitating better understanding amidst market volatility. Keeping abreast of such details allows investors to make strategic decisions regarding their portfolios.

Frequently Asked Questions

What is the net asset value of Octopus AIM VCT 2 plc?

The unaudited net asset value of the Ordinary shares is approximately 42.1 pence per share.

Why is net asset value important for investors?

Net asset value helps investors assess the value of an investment fund and make informed decisions based on asset performance.

How often does Octopus AIM VCT 2 plc update its NAV?

The company typically provides regular updates to ensure transparency and keep investors informed about their investments.

Who can I contact for more information about Octopus AIM VCT 2 plc?

You can reach out to Rachel Peat at Octopus Company Secretarial Services Limited for inquiries regarding NAV or other investment details.

What is the LEI of Octopus AIM VCT 2 plc?

The Legal Entity Identifier (LEI) for Octopus AIM VCT 2 plc is 213800BW27BKJCI35L17.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 33

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 37

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 29

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 40

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from APA Corporation's Q3 2024 Financial Update

Updated Category News Views 291

Insights from APA Corporation's Q3 2024 Financial Update HOUSTON -- APA Corporation (Nasdaq: APA) has released key information regarding its third-quarter 2024 financial and operational results. This supplemental information serves as a guide for investors, analysts, and stakeholders to help them form their own estimates regarding the company's performance. Understanding...

Continue Reading
Exploring the Growing Trends in the US Coffee Market to 2034

Updated Category News Views 394

Insights on the US Coffee Market Growth The US coffee market is currently gearing up for an exciting decade ahead, with projections indicating it could reach USD 150.88 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.8% from 2025. This surge is largely influenced by shifting consumer preferences towards premium and specialty coffee, along with an...

Continue Reading
Insights into Great Lakes Dredge & Dock's Upcoming Earnings

Updated Category News Views 125

Understanding the Upcoming Earnings Announcement Great Lakes Dredge & Dock (NASDAQ: GLDD) is gearing up for its quarterly earnings report, and investors are eager to glean insights from the announcement. The anticipation is palpable as analysts forecast an earnings per share (EPS) of $0.09, signalling potential growth for the company. Market Reactions and Guidance It's...

Continue Reading
Calmére Estate Winery Sold, Signaling Growth in Napa Valley

Updated Category News Views 306

Calmére Estate Winery Changes Hands in Major Sale Napa Valley has long been a beacon for wine enthusiasts and savvy investors alike. The recent transaction involving Calmére Estate Winery showcases the continued potential of this iconic region. The winery, known for its exquisite Chardonnay and Pinot Noir, has been a part of the Carneros American Viticultural Area (AVA)...

Continue Reading
Mr. Splash Car Wash Partners with NBA Stars for Growth

Updated Category News Views 204

Mr. Splash Car Wash Takes a Strategic Step Forward Mr. Splash Car Wash, a notable name in the express car wash industry, has recently entered into a strategic partnership with NBA stars Giannis and Thanasis Antetokounmpo, along with Michael Carter-Williams. This collaboration aims to elevate the brand's presence in the Midwest, showcasing Mr. Splash's commitment to...

Continue Reading